Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
about
The management of osteoporosis in children.Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnoverThe assessment of fracture risk.Successes achieved and challenges ahead in translating biomarkers into clinical applications.Biochemical markers of bone turnover and clinical outcomes in men with prostate cancerBiochemical markers of bone turnover part II: clinical applications in the management of osteoporosisInfluence of bisphosphonate therapy on bone geometry, volumetric bone density and bone strength of femoral shaft in postmenopausal women with rheumatoid arthritisThe effect of sequential therapy for postmenopausal women with osteoporosis: A PRISMA-compliant meta-analysis of randomized controlled trials.Clinical application of biochemical markers of bone turnover.Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring.Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club.Use of combination therapy in the treatment of primary osteoporosis: protocol for a network meta-analysis of randomised trialsCurrent and future treatment options in osteoporosis.Antiresorptive therapies for osteoporosis: a clinical overview.Baseline mineralizing surface determines the magnitude of the bisphosphonate effect on cortical bone mineralization in postmenopausal osteoporotic patients.The Utility of Biomarkers in Osteoporosis Management.Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures: rationale, aims and organization of a Japanese Osteoporosis Intervention Trial (JOINT) initiated by the Research GroupUrinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment.The role of biochemical markers of bone turnover in osteoporosis management in clinical practice.Recommendations on the management of fragility fracture risk in women younger than 70 years.Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial.
P2860
Q30251490-BA939381-F657-462D-B651-43AD3FAC8315Q33572186-E158F8E4-1E5F-44A3-8436-431B1EA92CA3Q33685092-D4224255-165A-4667-88B6-4A15807631A2Q33954585-65754BCF-B877-40C1-AC12-EBA81DCB7FDBQ35022212-ABEC0DAA-4B59-479B-B6CE-C5B11026631EQ35053491-5200725D-7CC0-43DE-A9B1-9E21045FA3FEQ36095188-A8CB0ED8-ECD3-4F4F-9CCE-904EC7F5A3C9Q36215878-F178CFB1-8718-4F65-8926-40C8D72A726FQ36658915-9BBD162B-CDA8-4768-9A23-15D27DDC9981Q37176381-70594CBF-DE7B-4ADF-8330-98B3193A7FC3Q37250572-863DE106-763F-4266-8B46-5F73E3DE4A37Q37454589-51F387F4-6E01-4F64-BDE3-BD29D04C7731Q37843715-5BFEA902-8956-47FC-B4DB-1EEDA83B2FB7Q37926914-4A73E7AF-10B3-4E5F-A6D0-7BD60BC75F3DQ38599112-58F79AB9-B8BD-44CD-B8CB-929EB8413A02Q38921875-F6E67CB9-6607-43C7-AB4B-2027052A2F68Q39874235-AB7BE9A7-14E8-4E08-AD7D-26CFEF74EBB5Q39874552-8CCC72D2-D953-4540-9F13-36FB8C153A0FQ43259341-4D163B43-B834-4B28-955E-260DA18E6C76Q44278781-5EB519A7-F369-472E-8C0B-CA1298BBA3E4Q44961461-A1CE155E-DAC3-4101-895C-6D0391B0D12F
P2860
Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Relationship between pretreatm ...... omen treated with risedronate.
@en
Relationship between pretreatm ...... omen treated with risedronate.
@nl
type
label
Relationship between pretreatm ...... omen treated with risedronate.
@en
Relationship between pretreatm ...... omen treated with risedronate.
@nl
prefLabel
Relationship between pretreatm ...... omen treated with risedronate.
@en
Relationship between pretreatm ...... omen treated with risedronate.
@nl
P356
P1476
Relationship between pretreatm ...... women treated with risedronate
@en
P2093
Andreas Grauer
Ian Barton
P2860
P304
P356
10.1359/JBMR.0301231
P577
2003-12-16T00:00:00Z